Hillary Lum
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Advance Care Planning | 45 | 2024 | 205 | 16.440 |
Why?
| Palliative Care | 19 | 2025 | 725 | 3.950 |
Why?
| Patient Portals | 7 | 2024 | 42 | 3.240 |
Why?
| Dementia | 6 | 2025 | 227 | 2.490 |
Why?
| Primary Health Care | 15 | 2024 | 1680 | 2.180 |
Why?
| Patient Participation | 6 | 2024 | 414 | 2.130 |
Why?
| Caregivers | 13 | 2025 | 815 | 2.090 |
Why?
| Hospice Care | 5 | 2023 | 200 | 1.870 |
Why?
| Terminal Care | 6 | 2023 | 237 | 1.830 |
Why?
| Physicians | 9 | 2024 | 865 | 1.820 |
Why?
| Aged | 60 | 2025 | 22104 | 1.800 |
Why?
| Suicide, Assisted | 6 | 2024 | 25 | 1.790 |
Why?
| Communication | 15 | 2024 | 846 | 1.700 |
Why?
| Advance Directives | 9 | 2024 | 77 | 1.670 |
Why?
| Skilled Nursing Facilities | 7 | 2024 | 131 | 1.650 |
Why?
| Physician-Patient Relations | 9 | 2024 | 539 | 1.630 |
Why?
| Huntington Disease | 2 | 2024 | 49 | 1.590 |
Why?
| Electronic Health Records | 7 | 2024 | 975 | 1.470 |
Why?
| Documentation | 5 | 2024 | 184 | 1.340 |
Why?
| Parkinson Disease | 3 | 2020 | 463 | 1.290 |
Why?
| Aged, 80 and over | 24 | 2025 | 7086 | 1.290 |
Why?
| Humans | 117 | 2025 | 129652 | 1.270 |
Why?
| Pandemics | 7 | 2022 | 1488 | 1.260 |
Why?
| Surveys and Questionnaires | 21 | 2024 | 5406 | 1.250 |
Why?
| Volunteers | 2 | 2019 | 30 | 1.220 |
Why?
| Subacute Care | 5 | 2024 | 77 | 1.210 |
Why?
| Antibodies, Monoclonal | 9 | 2024 | 1367 | 1.180 |
Why?
| Hospices | 2 | 2022 | 89 | 1.170 |
Why?
| Heart Failure | 7 | 2023 | 2150 | 1.130 |
Why?
| Quality Improvement | 6 | 2023 | 1103 | 1.110 |
Why?
| Cognitive Dysfunction | 2 | 2022 | 346 | 1.090 |
Why?
| Qualitative Research | 14 | 2024 | 1235 | 1.000 |
Why?
| Home Care Services | 5 | 2023 | 246 | 0.990 |
Why?
| Male | 54 | 2025 | 63682 | 0.930 |
Why?
| Female | 59 | 2025 | 68777 | 0.910 |
Why?
| Authorship | 1 | 2024 | 45 | 0.890 |
Why?
| Home Health Aides | 1 | 2023 | 5 | 0.870 |
Why?
| Medical Marijuana | 3 | 2020 | 111 | 0.850 |
Why?
| Hospice and Palliative Care Nursing | 2 | 2023 | 74 | 0.830 |
Why?
| Life Support Care | 2 | 2020 | 30 | 0.820 |
Why?
| Medicare | 5 | 2024 | 720 | 0.820 |
Why?
| Group Processes | 2 | 2020 | 57 | 0.810 |
Why?
| Health Services for the Aged | 2 | 2020 | 72 | 0.790 |
Why?
| Health Knowledge, Attitudes, Practice | 5 | 2020 | 1279 | 0.790 |
Why?
| Antibodies, Neutralizing | 1 | 2024 | 265 | 0.780 |
Why?
| Feasibility Studies | 3 | 2024 | 868 | 0.750 |
Why?
| Middle Aged | 25 | 2025 | 31155 | 0.750 |
Why?
| Practice Patterns, Physicians' | 3 | 2019 | 1266 | 0.720 |
Why?
| Patient Care Team | 3 | 2021 | 605 | 0.720 |
Why?
| Outpatients | 2 | 2024 | 370 | 0.710 |
Why?
| Living Wills | 1 | 2020 | 7 | 0.710 |
Why?
| Housing | 1 | 2022 | 130 | 0.700 |
Why?
| Music Therapy | 1 | 2020 | 22 | 0.700 |
Why?
| Patient-Centered Care | 3 | 2021 | 505 | 0.690 |
Why?
| Music | 1 | 2020 | 39 | 0.680 |
Why?
| Virtual Reality | 1 | 2020 | 52 | 0.660 |
Why?
| Inservice Training | 2 | 2017 | 114 | 0.650 |
Why?
| Neurodegenerative Diseases | 1 | 2021 | 113 | 0.650 |
Why?
| Internship and Residency | 2 | 2021 | 1053 | 0.640 |
Why?
| Ambulatory Care Facilities | 2 | 2019 | 228 | 0.620 |
Why?
| Pharmacists | 1 | 2021 | 247 | 0.620 |
Why?
| Attitude of Health Personnel | 7 | 2024 | 1098 | 0.620 |
Why?
| Activities of Daily Living | 1 | 2022 | 384 | 0.610 |
Why?
| CD40 Antigens | 4 | 2006 | 88 | 0.600 |
Why?
| Sports | 1 | 2021 | 225 | 0.600 |
Why?
| Resuscitation Orders | 4 | 2024 | 46 | 0.600 |
Why?
| Stakeholder Participation | 1 | 2019 | 77 | 0.600 |
Why?
| Hospitalization | 5 | 2023 | 2070 | 0.590 |
Why?
| Independent Living | 2 | 2018 | 98 | 0.590 |
Why?
| Long-Term Care | 3 | 2024 | 92 | 0.570 |
Why?
| Geriatric Assessment | 2 | 2024 | 205 | 0.570 |
Why?
| Betacoronavirus | 1 | 2020 | 249 | 0.560 |
Why?
| Patient Discharge | 5 | 2024 | 857 | 0.550 |
Why?
| Nursing Homes | 4 | 2024 | 159 | 0.550 |
Why?
| Alzheimer Disease | 1 | 2023 | 519 | 0.540 |
Why?
| Geriatrics | 3 | 2024 | 81 | 0.540 |
Why?
| Clinical Protocols | 1 | 2018 | 255 | 0.530 |
Why?
| Perception | 2 | 2020 | 340 | 0.530 |
Why?
| Physicians, Primary Care | 1 | 2019 | 230 | 0.530 |
Why?
| Social Media | 1 | 2019 | 137 | 0.520 |
Why?
| Interviews as Topic | 5 | 2024 | 717 | 0.520 |
Why?
| Marijuana Use | 4 | 2020 | 192 | 0.500 |
Why?
| Nurse Practitioners | 1 | 2018 | 132 | 0.500 |
Why?
| Patient Education as Topic | 5 | 2019 | 743 | 0.500 |
Why?
| Pneumonia, Viral | 1 | 2020 | 341 | 0.490 |
Why?
| Coronavirus Infections | 1 | 2020 | 335 | 0.490 |
Why?
| Policy | 1 | 2016 | 144 | 0.480 |
Why?
| Cardiotonic Agents | 1 | 2015 | 126 | 0.470 |
Why?
| Health Services Accessibility | 2 | 2021 | 902 | 0.460 |
Why?
| Drug Utilization | 1 | 2015 | 171 | 0.460 |
Why?
| Life Change Events | 1 | 2015 | 148 | 0.450 |
Why?
| Patient Readmission | 4 | 2021 | 667 | 0.430 |
Why?
| Education, Medical | 1 | 2017 | 244 | 0.430 |
Why?
| Patient Care Planning | 3 | 2020 | 149 | 0.430 |
Why?
| Cross-Sectional Studies | 6 | 2024 | 5066 | 0.430 |
Why?
| Physician's Role | 1 | 2015 | 206 | 0.420 |
Why?
| Decision Making | 4 | 2017 | 851 | 0.420 |
Why?
| Quality Assurance, Health Care | 1 | 2015 | 318 | 0.410 |
Why?
| Nurses | 1 | 2015 | 164 | 0.400 |
Why?
| Pilot Projects | 6 | 2024 | 1587 | 0.400 |
Why?
| Emergency Service, Hospital | 1 | 2023 | 1902 | 0.380 |
Why?
| Emergency Medical Services | 1 | 2018 | 522 | 0.380 |
Why?
| Canada | 5 | 2023 | 350 | 0.370 |
Why?
| Culture | 1 | 2012 | 124 | 0.370 |
Why?
| United States | 13 | 2024 | 13903 | 0.360 |
Why?
| Melanoma, Experimental | 3 | 2006 | 108 | 0.360 |
Why?
| Quality of Life | 3 | 2023 | 2704 | 0.360 |
Why?
| Interpersonal Relations | 1 | 2014 | 392 | 0.350 |
Why?
| Health Status | 1 | 2016 | 755 | 0.350 |
Why?
| Depression | 3 | 2018 | 1307 | 0.350 |
Why?
| Patients | 1 | 2012 | 167 | 0.350 |
Why?
| Retrospective Studies | 7 | 2024 | 14518 | 0.340 |
Why?
| Health Information Exchange | 2 | 2021 | 19 | 0.340 |
Why?
| Brain Neoplasms | 1 | 2019 | 1171 | 0.340 |
Why?
| Adult | 12 | 2024 | 35577 | 0.330 |
Why?
| Telemedicine | 3 | 2024 | 788 | 0.310 |
Why?
| Electronic Mail | 2 | 2019 | 60 | 0.310 |
Why?
| Health Communication | 2 | 2019 | 40 | 0.290 |
Why?
| Influenza, Human | 1 | 2014 | 601 | 0.290 |
Why?
| Peer Group | 2 | 2020 | 225 | 0.290 |
Why?
| Neuroblastoma | 2 | 2006 | 154 | 0.280 |
Why?
| Hospital Mortality | 1 | 2012 | 850 | 0.280 |
Why?
| Colorado | 9 | 2024 | 4421 | 0.280 |
Why?
| Organizations, Nonprofit | 1 | 2007 | 17 | 0.280 |
Why?
| Clinical Decision-Making | 2 | 2022 | 303 | 0.270 |
Why?
| Referral and Consultation | 4 | 2024 | 733 | 0.260 |
Why?
| Social Work | 3 | 2024 | 83 | 0.260 |
Why?
| Health Resources | 1 | 2007 | 114 | 0.260 |
Why?
| Automobile Driving | 2 | 2019 | 140 | 0.240 |
Why?
| Immunotherapy | 2 | 2008 | 592 | 0.240 |
Why?
| Anti-Retroviral Agents | 1 | 2007 | 231 | 0.240 |
Why?
| Immunization, Passive | 1 | 2005 | 87 | 0.230 |
Why?
| Multimorbidity | 1 | 2025 | 46 | 0.230 |
Why?
| Telerehabilitation | 1 | 2025 | 36 | 0.230 |
Why?
| Antibodies, Bispecific | 1 | 2005 | 49 | 0.220 |
Why?
| Internet | 2 | 2018 | 617 | 0.220 |
Why?
| Neoplasms | 3 | 2024 | 2470 | 0.220 |
Why?
| Loneliness | 1 | 2024 | 39 | 0.220 |
Why?
| Oncologists | 1 | 2024 | 35 | 0.220 |
Why?
| Social Isolation | 1 | 2024 | 60 | 0.220 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 2004 | 0.220 |
Why?
| Elder Abuse | 1 | 2024 | 47 | 0.210 |
Why?
| T-Lymphocytes | 4 | 2006 | 1928 | 0.210 |
Why?
| Healthcare Disparities | 2 | 2021 | 578 | 0.210 |
Why?
| Sleep Aids, Pharmaceutical | 1 | 2022 | 2 | 0.200 |
Why?
| Information Dissemination | 1 | 2024 | 206 | 0.200 |
Why?
| Interleukin-2 | 3 | 2009 | 436 | 0.190 |
Why?
| Potentially Inappropriate Medication List | 1 | 2021 | 16 | 0.190 |
Why?
| Death | 1 | 2022 | 121 | 0.190 |
Why?
| Macrophages, Peritoneal | 3 | 2006 | 91 | 0.180 |
Why?
| Macrophages | 2 | 2006 | 1480 | 0.180 |
Why?
| Digital Divide | 1 | 2021 | 3 | 0.180 |
Why?
| HIV-1 | 1 | 2007 | 836 | 0.180 |
Why?
| Perioperative Care | 1 | 2022 | 152 | 0.180 |
Why?
| Patient Selection | 1 | 2025 | 663 | 0.180 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2006 | 1198 | 0.180 |
Why?
| Comorbidity | 2 | 2016 | 1547 | 0.180 |
Why?
| Hearing Loss | 1 | 2024 | 210 | 0.180 |
Why?
| Nitric Oxide | 1 | 2006 | 902 | 0.180 |
Why?
| Deprescriptions | 1 | 2021 | 34 | 0.180 |
Why?
| Personhood | 1 | 2020 | 5 | 0.180 |
Why?
| Geriatric Psychiatry | 1 | 2020 | 12 | 0.170 |
Why?
| Macrophage Activation | 3 | 2006 | 189 | 0.170 |
Why?
| Program Evaluation | 1 | 2025 | 875 | 0.170 |
Why?
| Receptors, GABA-A | 1 | 2021 | 127 | 0.170 |
Why?
| Multiple Chronic Conditions | 1 | 2020 | 29 | 0.170 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 152 | 0.170 |
Why?
| Health Expenditures | 1 | 2021 | 179 | 0.160 |
Why?
| Organization and Administration | 1 | 2019 | 10 | 0.160 |
Why?
| Veterans | 2 | 2025 | 1398 | 0.160 |
Why?
| Mass Screening | 1 | 2007 | 1149 | 0.160 |
Why?
| Europe | 1 | 2020 | 364 | 0.160 |
Why?
| Patient Preference | 2 | 2022 | 185 | 0.160 |
Why?
| Health Plan Implementation | 1 | 2020 | 137 | 0.160 |
Why?
| Reimbursement Mechanisms | 1 | 2019 | 84 | 0.160 |
Why?
| Software Design | 1 | 2018 | 23 | 0.150 |
Why?
| Delphi Technique | 2 | 2017 | 225 | 0.150 |
Why?
| Inpatients | 1 | 2023 | 467 | 0.150 |
Why?
| Medical Futility | 1 | 2018 | 24 | 0.150 |
Why?
| Recreation | 1 | 2018 | 21 | 0.150 |
Why?
| Prognosis | 2 | 2018 | 3794 | 0.150 |
Why?
| Community-Institutional Relations | 1 | 2019 | 95 | 0.150 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 1501 | 0.150 |
Why?
| Patient Navigation | 1 | 2020 | 79 | 0.150 |
Why?
| Developed Countries | 1 | 2018 | 34 | 0.150 |
Why?
| Delivery of Health Care, Integrated | 1 | 2021 | 248 | 0.150 |
Why?
| Decision Making, Computer-Assisted | 1 | 2018 | 18 | 0.150 |
Why?
| Cytotoxicity, Immunologic | 4 | 2006 | 220 | 0.150 |
Why?
| Needs Assessment | 1 | 2020 | 360 | 0.150 |
Why?
| Rural Population | 1 | 2022 | 518 | 0.140 |
Why?
| Mentoring | 1 | 2020 | 131 | 0.140 |
Why?
| Research Personnel | 1 | 2019 | 156 | 0.140 |
Why?
| Ecosystem | 1 | 2022 | 568 | 0.140 |
Why?
| Prostatic Neoplasms | 1 | 2005 | 1016 | 0.140 |
Why?
| Video Recording | 1 | 2018 | 164 | 0.140 |
Why?
| Quality of Health Care | 1 | 2022 | 608 | 0.140 |
Why?
| Reading | 1 | 2018 | 150 | 0.130 |
Why?
| Longitudinal Studies | 2 | 2016 | 2717 | 0.130 |
Why?
| Program Development | 1 | 2019 | 357 | 0.130 |
Why?
| Academic Medical Centers | 1 | 2019 | 481 | 0.130 |
Why?
| Brain Ischemia | 1 | 2020 | 321 | 0.130 |
Why?
| Universities | 1 | 2019 | 408 | 0.130 |
Why?
| Health Services Research | 1 | 2019 | 391 | 0.130 |
Why?
| Community Health Services | 1 | 2018 | 227 | 0.130 |
Why?
| Neoplasms, Experimental | 2 | 2008 | 171 | 0.130 |
Why?
| Hypesthesia | 1 | 2016 | 16 | 0.130 |
Why?
| Cannabis | 2 | 2020 | 465 | 0.130 |
Why?
| Pain Management | 1 | 2019 | 327 | 0.130 |
Why?
| Disease Management | 2 | 2019 | 589 | 0.120 |
Why?
| Housing for the Elderly | 1 | 2015 | 7 | 0.120 |
Why?
| Chest Pain | 1 | 2016 | 89 | 0.120 |
Why?
| Financing, Personal | 1 | 2015 | 26 | 0.120 |
Why?
| Terminology as Topic | 1 | 2017 | 204 | 0.120 |
Why?
| Workflow | 1 | 2016 | 155 | 0.120 |
Why?
| Evidence-Based Medicine | 1 | 2019 | 718 | 0.120 |
Why?
| Young Adult | 3 | 2021 | 12427 | 0.120 |
Why?
| Professional Role | 1 | 2016 | 158 | 0.120 |
Why?
| Curriculum | 1 | 2021 | 917 | 0.110 |
Why?
| Firearms | 1 | 2020 | 359 | 0.110 |
Why?
| Environment | 1 | 2016 | 343 | 0.110 |
Why?
| Cell Line, Tumor | 6 | 2009 | 3215 | 0.110 |
Why?
| Family Practice | 1 | 2018 | 456 | 0.110 |
Why?
| Communication Barriers | 1 | 2014 | 98 | 0.110 |
Why?
| Residence Characteristics | 1 | 2016 | 328 | 0.110 |
Why?
| Cytokines | 4 | 2006 | 2017 | 0.110 |
Why?
| Motivational Interviewing | 1 | 2015 | 101 | 0.110 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 985 | 0.100 |
Why?
| State Medicine | 1 | 2012 | 19 | 0.100 |
Why?
| HIV Infections | 1 | 2007 | 2720 | 0.100 |
Why?
| Patient Reported Outcome Measures | 1 | 2016 | 373 | 0.100 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 759 | 0.100 |
Why?
| Multivariate Analysis | 1 | 2016 | 1502 | 0.100 |
Why?
| Prospective Studies | 3 | 2024 | 7133 | 0.100 |
Why?
| Stroke | 1 | 2020 | 1071 | 0.090 |
Why?
| Attitude to Health | 1 | 2015 | 431 | 0.090 |
Why?
| Benzodiazepines | 2 | 2022 | 136 | 0.090 |
Why?
| Chronic Disease | 1 | 2017 | 1720 | 0.090 |
Why?
| Severity of Illness Index | 1 | 2018 | 2742 | 0.090 |
Why?
| Respiratory Mechanics | 1 | 1990 | 64 | 0.080 |
Why?
| Goals | 2 | 2022 | 160 | 0.080 |
Why?
| Prevalence | 1 | 2016 | 2564 | 0.080 |
Why?
| Mice, SCID | 2 | 2006 | 351 | 0.070 |
Why?
| Killer Cells, Natural | 3 | 2006 | 427 | 0.070 |
Why?
| Risk Factors | 3 | 2023 | 9765 | 0.070 |
Why?
| Recombinant Fusion Proteins | 2 | 2008 | 643 | 0.070 |
Why?
| Nigeria | 1 | 2007 | 16 | 0.070 |
Why?
| Adolescent | 3 | 2021 | 20394 | 0.070 |
Why?
| Treatment Outcome | 2 | 2020 | 10230 | 0.070 |
Why?
| Pulmonary Alveoli | 1 | 1990 | 400 | 0.070 |
Why?
| Mice, Inbred C57BL | 3 | 2006 | 5440 | 0.070 |
Why?
| Immunologic Memory | 1 | 2009 | 349 | 0.070 |
Why?
| Mice | 8 | 2009 | 16937 | 0.070 |
Why?
| Hospitals | 2 | 2022 | 637 | 0.070 |
Why?
| Colonic Neoplasms | 1 | 2009 | 243 | 0.070 |
Why?
| Religion | 1 | 2007 | 68 | 0.070 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2006 | 48 | 0.060 |
Why?
| Mice, Inbred A | 1 | 2006 | 48 | 0.060 |
Why?
| Subcutaneous Tissue | 1 | 2006 | 22 | 0.060 |
Why?
| Stress, Psychological | 1 | 2014 | 1066 | 0.060 |
Why?
| Toll-Like Receptor 9 | 1 | 2006 | 31 | 0.060 |
Why?
| Vaccination | 1 | 2014 | 1348 | 0.060 |
Why?
| Neoplasm Transplantation | 1 | 2006 | 257 | 0.060 |
Why?
| Mice, Mutant Strains | 1 | 2006 | 298 | 0.060 |
Why?
| Nitric Oxide Synthase | 1 | 2006 | 237 | 0.060 |
Why?
| Self Report | 2 | 2019 | 799 | 0.060 |
Why?
| Antigen Presentation | 1 | 2006 | 206 | 0.060 |
Why?
| CD3 Complex | 1 | 2005 | 103 | 0.060 |
Why?
| Conscience | 1 | 2024 | 7 | 0.060 |
Why?
| Tumor Cells, Cultured | 1 | 2006 | 940 | 0.060 |
Why?
| Lymphocyte Activation | 2 | 2006 | 1106 | 0.060 |
Why?
| Animals | 10 | 2009 | 35361 | 0.050 |
Why?
| Immunoconjugates | 1 | 2005 | 103 | 0.050 |
Why?
| Terminally Ill | 1 | 2023 | 35 | 0.050 |
Why?
| Epidemics | 1 | 2024 | 82 | 0.050 |
Why?
| Morals | 1 | 2023 | 71 | 0.050 |
Why?
| Specialization | 1 | 2024 | 145 | 0.050 |
Why?
| Disclosure | 1 | 2023 | 110 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2006 | 827 | 0.050 |
Why?
| Lipopolysaccharides | 1 | 2006 | 875 | 0.050 |
Why?
| Age Factors | 2 | 2020 | 3144 | 0.050 |
Why?
| Pregnancy Proteins | 1 | 2002 | 37 | 0.050 |
Why?
| Receptor, ErbB-2 | 1 | 2005 | 326 | 0.050 |
Why?
| Adenocarcinoma | 1 | 2009 | 898 | 0.050 |
Why?
| Patient Care | 1 | 2023 | 109 | 0.050 |
Why?
| Cohort Studies | 1 | 2012 | 5420 | 0.050 |
Why?
| Interferon-gamma | 1 | 2005 | 770 | 0.050 |
Why?
| Asia | 1 | 2021 | 58 | 0.040 |
Why?
| Pharmaceutical Preparations | 1 | 2022 | 171 | 0.040 |
Why?
| Neutrophils | 1 | 2006 | 1205 | 0.040 |
Why?
| Thrombectomy | 1 | 2020 | 59 | 0.040 |
Why?
| Ownership | 1 | 2020 | 87 | 0.040 |
Why?
| Senior Centers | 1 | 2019 | 1 | 0.040 |
Why?
| Mortality | 1 | 2021 | 307 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2020 | 284 | 0.040 |
Why?
| Confidentiality | 1 | 2019 | 68 | 0.040 |
Why?
| Interprofessional Relations | 1 | 2021 | 277 | 0.040 |
Why?
| Vulnerable Populations | 1 | 2020 | 158 | 0.040 |
Why?
| Safety | 1 | 2020 | 331 | 0.040 |
Why?
| Professional-Patient Relations | 1 | 2019 | 140 | 0.040 |
Why?
| Minority Health | 1 | 2018 | 20 | 0.040 |
Why?
| Informed Consent | 1 | 2019 | 170 | 0.040 |
Why?
| Social Values | 1 | 2018 | 34 | 0.040 |
Why?
| Rats | 1 | 2006 | 5500 | 0.030 |
Why?
| Interdisciplinary Research | 1 | 2017 | 26 | 0.030 |
Why?
| California | 1 | 2018 | 401 | 0.030 |
Why?
| Internationality | 1 | 2017 | 149 | 0.030 |
Why?
| Patient Safety | 1 | 2019 | 287 | 0.030 |
Why?
| Students | 1 | 2021 | 580 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2020 | 1214 | 0.030 |
Why?
| Racism | 1 | 2018 | 129 | 0.030 |
Why?
| Time Factors | 3 | 2020 | 6556 | 0.030 |
Why?
| Risk Assessment | 1 | 2024 | 3240 | 0.030 |
Why?
| Personal Autonomy | 1 | 2015 | 48 | 0.030 |
Why?
| Delivery of Health Care | 1 | 2020 | 894 | 0.030 |
Why?
| Flow Cytometry | 2 | 2008 | 1156 | 0.030 |
Why?
| Empathy | 1 | 2015 | 170 | 0.020 |
Why?
| Pain | 1 | 2018 | 789 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2020 | 3083 | 0.020 |
Why?
| Anxiety | 1 | 2018 | 966 | 0.020 |
Why?
| Spleen | 2 | 2004 | 507 | 0.020 |
Why?
| Lung Volume Measurements | 1 | 1990 | 45 | 0.020 |
Why?
| Gerbillinae | 1 | 1990 | 64 | 0.020 |
Why?
| Cell Membrane Permeability | 1 | 1989 | 81 | 0.020 |
Why?
| Pressure | 1 | 1990 | 237 | 0.020 |
Why?
| Albumins | 1 | 1989 | 103 | 0.020 |
Why?
| Thrombin | 1 | 1989 | 146 | 0.020 |
Why?
| Peptides, Cyclic | 1 | 1989 | 256 | 0.020 |
Why?
| Child | 1 | 2007 | 20883 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2009 | 1245 | 0.020 |
Why?
| Apoptosis | 2 | 2006 | 2503 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2009 | 1206 | 0.020 |
Why?
| Catheter Ablation | 1 | 2009 | 335 | 0.020 |
Why?
| Cell Division | 2 | 2002 | 797 | 0.020 |
Why?
| Leukemia L5178 | 1 | 2005 | 1 | 0.020 |
Why?
| CpG Islands | 1 | 2006 | 152 | 0.020 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2008 | 814 | 0.010 |
Why?
| Jurkat Cells | 1 | 2005 | 134 | 0.010 |
Why?
| Mice, Inbred C3H | 1 | 2005 | 273 | 0.010 |
Why?
| Liver Neoplasms, Experimental | 1 | 2004 | 28 | 0.010 |
Why?
| Coculture Techniques | 1 | 2005 | 226 | 0.010 |
Why?
| Gangliosides | 1 | 2004 | 19 | 0.010 |
Why?
| Immunophenotyping | 1 | 2006 | 311 | 0.010 |
Why?
| Cytoplasm | 1 | 2005 | 263 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 2004 | 406 | 0.010 |
Why?
| Ligands | 1 | 2005 | 622 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1989 | 901 | 0.010 |
Why?
| Megakaryocytes | 1 | 2002 | 32 | 0.010 |
Why?
| CHO Cells | 1 | 2002 | 153 | 0.010 |
Why?
| Cricetinae | 1 | 2002 | 277 | 0.010 |
Why?
| Neoplasm Metastasis | 1 | 2004 | 610 | 0.010 |
Why?
| Bone Marrow Cells | 1 | 2002 | 300 | 0.010 |
Why?
| Hematopoietic Stem Cells | 1 | 2002 | 381 | 0.010 |
Why?
| Gestational Age | 1 | 2002 | 874 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2002 | 1304 | 0.010 |
Why?
| Mice, Knockout | 1 | 2005 | 2871 | 0.010 |
Why?
| Fetus | 1 | 2002 | 773 | 0.010 |
Why?
| Cell Differentiation | 1 | 2002 | 1902 | 0.010 |
Why?
| Cells, Cultured | 1 | 2002 | 4083 | 0.010 |
Why?
| Pregnancy | 1 | 2002 | 6402 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1989 | 400 | 0.000 |
Why?
| Actins | 1 | 1989 | 411 | 0.000 |
Why?
| Cattle | 1 | 1989 | 976 | 0.000 |
Why?
| Cell Survival | 1 | 1989 | 1086 | 0.000 |
Why?
| Cell Membrane | 1 | 1989 | 732 | 0.000 |
Why?
|
|
Lum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|